Trends in the management of esophageal carcinoma based on provider volume: Treatment practices of 618 esophageal surgeons

Diseases of the Esophagus

Volumn 23, Issue 2, 2010, Pages 136-144

  Enestvedt, C K ^a   Perry, K A ^a   Kim, C ^a   McConnell, P W ^b   Diggs, B S ^a   Vernon, A ^c   O'Rourke, R W ^a   Luketich, J D ^d   Hunter, J G ^a   Jobe, B A ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Esophageal cancer; Esophagectomy; Esophagus; Minimally invasive esophagectomy

Indexed keywords

ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CLINICAL PRACTICE; CONTROLLED STUDY; END TO END ANASTOMOSIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; MALE; MINIMALLY INVASIVE SURGERY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; THORAX SURGERY; TREND STUDY; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANASTOMOSIS; CANCER STAGING; CARCINOMA; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; ESOPHAGEAL NEOPLASMS; GENERAL SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MIDDLE AGED; ONCOLOGY; PALLIATIVE THERAPY; PRIVATE PRACTICE; PROCEDURES; STATISTICS AND NUMERICAL DATA; STENT; SURGICAL STAPLING; SUTURING METHOD; UNIVERSITY HOSPITAL; WORKLOAD;

ACADEMIC MEDICAL CENTERS; ANASTOMOSIS, SURGICAL; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DIAGNOSTIC IMAGING; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GENERAL SURGERY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; NEOADJUVANT THERAPY; NEOPLASM STAGING; PALLIATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; PRIVATE PRACTICE; RADIOTHERAPY, ADJUVANT; SPECIALTIES, SURGICAL; STENTS; SURGICAL STAPLING; SUTURE TECHNIQUES; THORACIC SURGERY; WORKLOAD;

EID: 77953159379     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.00985.x     Document Type: Article

References (40)

1. Bailey S H, Bull D A, Harpole D H et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003; 75: 217-22; discussion 222.
2. Urschel J D. Esophagogastrostomy anastomotic leaks complicating esophagectomy: a review. Am J Surg 1995; 169: 634-40.
3. Briel J W, Tamhankar A P, Hagen J A et al. Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 2004; 198: 536-41; discussion 541-542.
4. Jobe B A, Kim C Y, Minjarez R C, O'Rourke R, Chang E Y, Hunter J G. Simplifying minimally invasive transhiatal esophagectomy with the inversion approach: lessons learned from the first 20 cases. Arch Surg 2006; 141: 857-65; discussion 865-866.
5. Law S, Fok M, Chu K M, Wong J. Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg 1997; 226: 169-73.
6. Hulscher J B, Tijssen J G, Obertop H, van Lanschot J J. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001; 72: 306-13.
7. Orringer M B, Marshall B, Iannettoni M D. Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg 2000; 119: 277-88.
8. Luketich J D, Alvelo-Rivera M, Buenaventura P O et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003; 238: 486-94; discussion 494-495.
9. Braghetto I, Csendes A, Cardemil G, Burdiles P, Korn O, Valladares H. Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg Endosc 2006; 20: 1681-6.
10. Jin J, Liao Z, Zhang Z et al. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004; 60: 427-36.
11. Birkmeyer J D, Finlayson E V, Birkmeyer C M. Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiative. Surgery 2001; 130: 415-22.
12. Birkmeyer J D, Siewers A E, Finlayson E V et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-37.
13. Birkmeyer J D, Stukel T A, Siewers A E, Goodney P P, Wennberg D E, Lucas F L. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349: 2117-27.
14. Birkmeyer J D, Sun Y, Wong S L, Stukel T A. Hospital volume and late survival after cancer surgery. Ann Surg 2007; 245: 777-83.
15. Rodgers M, Jobe B A, O'Rourke R W, Sheppard B, Diggs B, Hunter J G. Case volume as a predictor of inpatient mortality after esophagectomy. Arch Surg 2007; 142: 829-39.
16. Walther B, Johansson J, Johnsson F, Von Holstein C S, Zilling T. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg 2003; 238: 803-12; discussion 812-814.
17. Hulscher J B, van Sandick J W, de Boer A G et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
18. Gu Y, Swisher S G, Ajani J A et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 2006; 106: 1017-25.
19. Lerut T, Nafteux P, Moons J et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004; 240: 962-72; discussion 972-964.
20. Chang E Y, Smith C A, Corless C L, Thomas C R Jr, Hunter J G, Jobe B A. Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer. Am J Surg 2007; 193: 614-7; discussion 617.
21. Ouellette J R, Ko A S, Lefor A T. The physiologic effects of laparoscopy: applications in oncology. Cancer J 2005; 11: 2-9.
22. Paraskeva P A, Purkayastha S, Darzi A. Laparoscopy for malignancy: current status. Semin Laparosc Surg 2004; 11: 27-36.
23. Shpitz B, Klein E. Port-site metastasis after minimally invasive cancer surgery. Surg Endosc 2003; 17: 1503-4; author reply 1505.
24. Edwards M J, Gable D R, Lentsch A B, Richardson J D. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996; 223: 585-9; discussion 589-591.
25. Sujendran V, Sica G, Warren B, Maynard N. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. Eur J Cardiothorac Surg 2005; 28: 763-6.
26. Banki F, Mason R J, DeMeester S R et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 2002; 236: 324-35; discussion 335-336.
27. Swisher S G, Maish M, Erasmus J J et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 2004; 78: 1152-60; discussion 1152-1160.
28. Westerterp M, van Westreenen H L, Reitsma J B et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy - systematic review. Radiology 2005; 236: 841-51.
29. Song S Y, Kim J H, Ryu J S et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1053-9.
30. WallaceMB, Nietert P J, Earle C et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 2002; 74: 1026-32.
31. Pfau P R, Perlman S B, Stanko P et al. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc 2007; 65: 377-84.
32. Rasanen J V, Sihvo E I, Knuuti M J et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003; 10: 954-60.
33. Lightdale C J, Kulkarni K G. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 2005; 23: 4483-9.
34. Penman I D, Henry E. Advanced esophageal cancer. Gastrointest Endosc Clin N Am 2005; 15: 101-16, ix.
35. Rosch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995; 5: 537-47.
36. Wiersema M J, Vilmann P, Giovannini M, Chang K J, Wiersema LM. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112: 1087-95.
37. Eloubeidi M A, Wallace M B, Reed C E et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience. Gastrointest Endosc 2001; 54: 714-9.
38. Kaushik N, Khalid A, Brody D, Luketich J, McGrath K. Endoscopic ultrasound compared with laparoscopy for staging esophageal cancer. Ann Thorac Surg 2007; 83: 2000-2.
39. Bergquist H, Wenger U, Johnsson E et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 2005; 18: 131-9.
40. Ross W A, Alkassab F, Lynch P M et al. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 2007; 65: 70-6.